Aspirin study
This article was originally published in The Tan Sheet
Executive Summary
"Aspirin resistance" findings in study of high-risk cardiovascular patients may have resulted from poor aspirin regimen compliance, Bayer says in response to trial published in March 26 Circulation. Conducted by John Eikelboom, University of Western Australia, et al., study looked at 488 individuals with potential aspirin resistance out of 5,529 subjects enrolled in Heart Outcomes Prevention Evaluation Study. Such individuals may "benefit from additional antiplatelet therapies or treatments that more effectively block in vivo thromboxane production or activity," researchers say...
|
"Aspirin resistance" findings in study of high-risk cardiovascular patients may have resulted from poor aspirin regimen compliance, Bayer says in response to trial published in March 26 Circulation. Conducted by John Eikelboom, University of Western Australia, et al., study looked at 488 individuals with potential aspirin resistance out of 5,529 subjects enrolled in Heart Outcomes Prevention Evaluation Study. Such individuals may "benefit from additional antiplatelet therapies or treatments that more effectively block in vivo thromboxane production or activity," researchers say.... |